Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
JST heads into its November 12 results with the stock under quiet but persistent pressure, down 5% over the past month to EUR 58.90, and the lending market offering no read-through to meaningful short conviction.
The borrow market tells a story of near-total disinterest from short sellers. Availability is extremely loose at 2,844%, meaning shares available to borrow dwarf the current short position by a wide margin. That reading has tightened from above 4,500% in late September, but it remains comfortably above the 52-week low of 1,651%, so the direction of travel reflects normal portfolio flows rather than any coordinated build in short positions. Cost to borrow is similarly benign at 0.73%, roughly unchanged on the week and well within its recent range. The ORTEX short score of 33.0 sits in the 51st percentile on a short-score rank basis, a mid-table reading that points to a broadly neutral short-side stance. Nothing in the lending data suggests shorts are pressing the thesis ahead of the print.
The valuation picture is where things get more interesting. At a PE of 8.6x and an EV/EBITDA of 6.2x, JST trades at a discount that stands out even within a sector that has been re-rated lower. Both multiples have compressed further over the past 30 days, the PE slipping by roughly 0.3 turns and EV/EBITDA by 0.2 turns, as the stock drifted while underlying earnings estimates held firm. The forward earnings growth factor score ranks in the 91st percentile, and the dividend score is in the 96th percentile, a combination that usually attracts income-oriented institutional buyers rather than momentum traders. The analyst data on file is more than 18 months old with a mean target of EUR 63.52, which implies upside to current levels but cannot be relied upon as a current view. Recent analyst coverage has been too sparse to draw any directional read.
Peer performance adds context to the weekly slide. KBX fell 3.6% on the week, broadly in line with JST's 2.2% decline, while KGX dropped a sharper 13.6%, suggesting sector-wide pressure rather than company-specific selling. VOLV B and SKF B both fell less than 2% over the same period, which points to some differentiation within the heavy-transport complex. The ownership base is stable, with FMR holding around 9.1% and Allianz Asset Management at 8.8%, both unchanged in recent filings. Norges Bank Investment Management added roughly 95,000 shares in the quarter to June, a modest but constructive move from a typically long-only sovereign fund.
The insider record on file covers transactions from September 2025, which is now more than a year old and too stale to carry weight in the current setup. What remains on record, however, is a pattern worth noting: the CEO, CFO and COO each bought shares in September 2025 at prices in the EUR 47 to 49 range, well below where the stock trades today. That cluster of purchases at lower levels has not been followed by any disclosed selling, at least within the available data window.
With the next earnings event set for November 12, the most relevant question is whether the EBITDA margin expansion reported in H1 2026 carries into the second half, given softer European truck build rates and what the recent peer-group weakness implies about near-term order visibility across the trailer components segment.
See the live data behind this article on ORTEX.
Open JST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
